» Articles » PMID: 32538432

LncRNA GNAS-AS1 Facilitates ER+ Breast Cancer Cells Progression by Promoting M2 Macrophage Polarization Via Regulating MiR-433-3p/GATA3 Axis

Overview
Journal Biosci Rep
Specialty Cell Biology
Date 2020 Jun 16
PMID 32538432
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: ER+ breast cancer is the most common type of breast cancer, which seriously affects the physical and mental health of women. Recently, lncRNAs mediated tumor-associated macrophages (TAM) were identified to involve in tumorigenesis. Therefore, the present study aimed at demonstrating the regulatory network of GNAS-AS1 in TAM-mediated ER+ breast cancer progress.

Methods: The expression levels of genes were evaluated using qRT-PCR. The proportions of polarized macrophages (M1, M2) were assessed by flow cytometry. Cell proliferation, migration and invasion were evaluated by CCK-8, wound healing and transwell assay, respectively. Double-luciferase reporter system was used to detect the interaction between molecules. Western blot was applied to test protein levels.

Results: The expression of GNAS-AS1 was obviously increased in ER+ breast cancer tissues and cell lines, as well as M2 macrophages. GNAS-AS1 facilitated the capabilities of proliferation, migration and invasion of ER+ breast cancer cells by accelerating M2 macrophage polarization via directly sponging miR-433-3p. GATA3, as a target of miR-433-3p, could positively regulate by GNAS-AS1. Furthermore, either miR-433-3p overexpression or GATA3 knockdown impaired the effects of GNAS-AS1 on M2 macrophage polarization and ER+ breast cancer cells progression.

Conclusion: GNAS-AS1/miR-433-3p/GATA3 axis promoted proliferation, metastasis of ER+ breast cancer cells by accelerating M2 macrophage polarization. The mechanism may provide a new strategy and target for ER+ breast cancer treatment.

Citing Articles

Macrophage subtypes inhibit breast cancer proliferation in culture.

Varady S, Greiner D, Roh-Johnson M Mol Biol Cell. 2024; 36(1):br2.

PMID: 39602294 PMC: 11742110. DOI: 10.1091/mbc.E24-06-0241.


Bioinformatic and experimental analyses of GATA3 and its regulatory miRNAs in breast Cancer.

Roohy F, Moghanibashi M, Tahmasebi S Discov Oncol. 2024; 15(1):588.

PMID: 39448444 PMC: 11502614. DOI: 10.1007/s12672-024-01479-y.


Non-coding RNAs as therapeutic targets in cancer and its clinical application.

Leng X, Zhang M, Xu Y, Wang J, Ding N, Yu Y J Pharm Anal. 2024; 14(7):100947.

PMID: 39149142 PMC: 11325817. DOI: 10.1016/j.jpha.2024.02.001.


Identification and analysis of epithelial-mesenchymal transition-related key long non-coding RNAs in hypospadias.

Gao H, Ding C, Chang M, Lu Z, Li D, Bi D IET Syst Biol. 2024; 18(4):143-154.

PMID: 39051498 PMC: 11336057. DOI: 10.1049/syb2.12096.


Macrophage subtypes inhibit breast cancer proliferation in culture.

Varady S, Greiner D, Roh-Johnson M bioRxiv. 2024; .

PMID: 38853881 PMC: 11160732. DOI: 10.1101/2024.06.01.596963.


References
1.
Levine M . An update on the clinical and molecular characteristics of pseudohypoparathyroidism. Curr Opin Endocrinol Diabetes Obes. 2012; 19(6):443-51. PMC: 3679535. DOI: 10.1097/MED.0b013e32835a255c. View

2.
Hung C, Chen F, Lin Y, Tsai M, Wang S, Chen Y . Altered monocyte differentiation and macrophage polarization patterns in patients with breast cancer. BMC Cancer. 2018; 18(1):366. PMC: 5883269. DOI: 10.1186/s12885-018-4284-y. View

3.
Miyasato Y, Shiota T, Ohnishi K, Pan C, Yano H, Horlad H . High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer. Cancer Sci. 2017; 108(8):1693-1700. PMC: 5543503. DOI: 10.1111/cas.13287. View

4.
Li Z, Feng C, Guo J, Hu X, Xie D . GNAS-AS1/miR-4319/NECAB3 axis promotes migration and invasion of non-small cell lung cancer cells by altering macrophage polarization. Funct Integr Genomics. 2019; 20(1):17-28. DOI: 10.1007/s10142-019-00696-x. View

5.
El-Arabey A, Denizli M, Kanlikilicer P, Bayraktar R, Ivan C, Rashed M . GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma. Cell Signal. 2020; 68:109539. DOI: 10.1016/j.cellsig.2020.109539. View